ArticlePharmaceuticals (Basel, Switzerland)2025

Tilianin Attenuates Myocardial Ischemia-Reperfusion Injury by Targeting RIP3-Mediated Necroptosis.

Ruifang Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.